Answers are grounded in this paper and cite their sources.
Pharmacovigilance analysis demonstrates associations between platinum agents and hypersensitivity reactions in treated patients, highlighting the utility of surveillance data mining.
The FDA's adverse event reporting system, AERS, with optimized data mining tools is useful to authorize potential associations between platinum agents and hypersensitivity reactions.
No takes yet. Share an insight, caveat, or question.
Sakaeda et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: